Historical antecedents of inflammatory bowel disease therapy

Inflammatory Bowel Diseases

Volumn 2, Issue 2, 1996, Pages 73-81

  Kirsner, Joseph B ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002187157     PISSN: 10780998     EISSN: None     Source Type: Journal    
DOI: 10.1002/ibd.3780020202     Document Type: Review

References (114)

1. Allchin WH. Ulcerative colitis. An address introductory to the subject. Proc Roy Soc Med 1909;2:59-75.
2. Haggard H, The doctors in history - New Haven 1934. In: MacKinney LC. Early medieval medicine. Baltimore: Johns Hopkins Press, 1937:33-4.
3. Manson P, Shaw TC, Phillips S, et al. A discussion on ulcerative colitis. Proc Roy Soc Lond 1969;2:95-6.
4. Dorfman W. Narco analysis in ulcerative colitis. NY State J Med 1952;52:2019-21.
5. Popp WC, Bargen JA, Dixon CF, Regional enteritis - roentgen therapy. Proc Mayo Clin 1950;25:1-5.
6. Logan AH. Three cases of chronic ulcerative colitis cured by iodine. Med Clin North Am 1923;7:105-12.
7. Herfort RA, Livingston H. Thiouracil drugs in treatment of chronic ulcerative colitis. NY State J Med 1952;52:431-6.
8. Burnford J. Ulcerative colitis - its treatment by ionization - summary of twenty eight cases. Br Med J 1930;2:640-41.
9. Cheney G. Injection of highly concentrated liver extract in treatment of idiopathic ulcerative colitis. Arch Intern Med 1939;63:813-29.
10. Ferguson LK, Fetter K, Schnabel TG. Artificial fever in the treatment of ulcerative colitis: a preliminary report. Am J Dig Dis 1937;4:487-8.
11. Schmelkes FD, Marks HC. N,N-Dichloro-azodicarbomidine (azochloramid), an N-chloro derivative of oxidant in an oxidation-reduction system. J Am Chem Soc 1934;56: 1610-2.
12. Burnham WR, Lennard-Jones JE, Hecketsweiler P, et al. Oral BCG vaccine in Crohn's disease. Gut 1979;20:229-33.
13. Portis S, Block L, Necheles H. Studies on chronic ulcerative colitis and some biological effects of detergents. Gastroenterology 1944;3:106-13.
14. Lups S. Vaccine therapy in ulcerative colitis. Am J Dig Dis Nutr 1935;2:65-90.
15. Maratka Z, Wagner F. The treatment of nonspecific ulcerative colitis by autogenous vaccine: correlated bacteriological and immunological studies. Gastroenterology 1948; 113:34-49.
16. Gill AM. Chronic ulcerative colitis clinial experiments with pig's intestine. Lancet 1944;246:536-7.
17. Ehrlich R. Treatment of chronic ulcerative colitis with fractional component of hog's stomach. Am J Dig Dis Nutr 1950;17:1-4.
18. Streicher MH, Grossman MI, Ivy AC. Preliminary report of a clinical trial of orally administered hog duodenum powder in the treatment of chronic ulcerative colitis. Gastroenterology 1949;12:371-4.
19. Friedman MHF, Haskell BF. Treatment of nonspecific ulcerative colitis for one year with extracts of intestinal mucosa. Gastroenterology 1946;11:833-41.
20. Hiatt RB. Abnormal intestinal motility as an etiological factor in inflammatory bowel disease. J Clin Gastroenterol 1984;6:201-3.
21. Schlitt RJ, McNally JJ, Shafiroff BGP, et al. Pelvic autonomic neurectomy for ulcerative colitis. Gastroenterology 1951;19:812-6.
22. Dennis C, Eddy FD. Response to vagotomy in idiopathic ulcerative colitis. Ann Surg 1948;128:479-86.
23. Cesnick H. Thymectomy in ulcerative colitis: promising results in seven patients. Langenbecks Arch Klin Chir 1968;321:86-98.
24. Sanpanet R, Bucaille M. Procaine injection of the prefrontal lobe of the brain-technic and present indications. Ann Surg 1955;141:388-97.
25. Crohn BB. Regional ileitis. In: Portis SA, ed. Diseases of the digestive system. Philadelphia: Lea & Febiger, 1941: 722-9.
26. Paulson M. Nonspecific or indeterminate ulcerative colitis. In: Portis SA, ed. Diseases of the digestive system. Philadelphia: Lea & Febiger, 1941:844-71.
27. Casten D. Nutritional disturbances in regional enteritis. Surgery 1939;6:708-16.
28. James AH. Breakfast and Crohn's disease. Br Med J 1977; 1:943-5.
29. Martini GA, Brandes JW. Increased consumption of refined carbohydrates in patients with Crohn's disease. Klin Wochenschr 1976;54:367-71.
30. Heaton KW, Thornton JR, Emmett PM. Treatment of Crohn's disease with an unrefined carbohydrate, fibre rich diet. Br Med J 1979;2:764-6.
31. Guthy E. Aetiologie der morbus Crohn. Deutsch Med Wochenschr 1983;45:1729-33.
32. Andresen AFR. Ulcerative colitis - an allergic phenomenon. Am J Dig Dis 1942;9:91-8.
33. Carstensen J. Food additives and their possible role in Crohn's disease. Z Gastroent [Suppl] 1979;17:145-53.
34. Tilden E, Miller E. The response of the monkey to the withdrawal of vitamin A from the diet. J Nutr 1930;3:121-40.
35. Kirsner JB, Sheffner AL, Palmer WL. Studies on amino acid excretion in man. V. Chronic ulcerative colitis and regional enteritis. J Clin Invest 1950;29:874-80.
36. Kirsner JB, Brandt MB, Sheffner AL. Diet and amino acid utilization in gastrointestinal disorders. J Am Diet Assoc 1953;29:1103-8.
37. Elman R, Weiner DO. Intravenous alimentation - with special reference to protein (amino acid) metabolism. JAMA 1939;112:796-802.
38. Machella TE, Miller TG. Treatment of idiopathic ulcerative colitis by means of a "medical ileostomy" and an orally-administered protein hydrolysate-dextrimaltose mixture. Gastroenterology 1948;10:28-45.
39. Dudrick S, Wilmore DW, Vars HM, Rhoads JE. Longterm total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery 1968;64:134-42.
40. Dudrick S, Wilmore DW, Vars HM, Rhoads JE. Can intravenous feeding as the sole means of nutrition support growth in the child and restore weight loss in an adult? An affirmative answer. Ann Surg 1969;169:974-84.
41. Vilaseca J, Salas A, Guarner F, et al. Dietary fish oil reduces progression of chronic inflammatory lesions in rat model of granulomatous colitis. Gut 1990;31:539-44.
42. Grace WJ, Pinsky RH, Wolff H. Treatment of ulcerative colitis. Gastroenterology 1954;26:462-8.
43. Karush A, Daniels GE, Flood CF, et al. Psychotherapy in chronic ulcerative colitis. Philadelphia: Saunders, 1977.
44. Almy TP. Psychosocial aspects of chronic ulcerative colitis and Crohn's disease. In: Kirsner JB, Shorter RG, eds. Inflammatory bowel disease. Philadelphia: Lea Febiger, 1980:44-54.
45. Feldman F, Cantor D, Soil S, Bachrach W. Psychiatric study of a consecutive series of 34 patients with ulcerative colitis. Br Med J 1967;2:14-7.
46. Helzer JE, Stillings WA, Chammes S, et al. A controlled study of the association between ulcerative colitis and psychiatric diagnoses. Dig Dis Sci 1982;27:513-8.
47. North CS, Clouse RE, Spitznagel EL, Alpers DH. The relation of ulcerative colitis to psychiatric factors: a review of findings and methods. Am J Psychiatry 1990;147:974-81.
48. Helzer JE, Chammas S, Norland CC, et al. A study of the association between Crohn's disease and psychiatric illness. Gastroenterology 1984;86:324-30.
49. Domagk G. Ein Beitrag Zur Chemotherapie der Bakteriellen Infektionen. Deutsch Med Wochenschr 1935;61: 250-3.
50. Rodaniche EC, Kirsner JB, Palmer WL. Effect of oral administration of sulfonamide compounds in the fecal flora of patients with nonspecific ulcerative colitis. Gastroenterology 1943;1:133-9.
51. Marshall HC, Palmer WL, Kirsner JB. Effects of chemotherapeutic agents on fecal bacteria in patients with chronic ulcerative colitis. JAMA 1950;144:900-3.
52. Cooke EM. Fecal flora of patients with ulcerative colitis during treatment with salicylazosulphapyridine. Gut 1967; 10:565-8.
53. Svartz N, Kallner S. Sulfonamide preparations and continued investigations on complications after treatment with brief report on new therapeutic experiments, Fortsatta Undersokningar Over Biverkningar Vid Behandling Med Sulfonamid-preparat Samt en Kort Redogorelse fur Nya Terapeutiska Forsok. Nord Med 1940;8:1935-40.
54. Svartz N. Salazopyrin - a new sulfanilamide preparation. A. Therapeutic result in rheumatoid arthritis. B. Therapeutic results in ulcerative colitis. C. Toxic manifestations on treatment with sulfanilamide preparations. Acta Med Scand 1942;110:577-90.
55. [also Nord Med 1941;11:2261-2.]
56. Bachrach WH. Sulfasalazine. I. An historical perspective. Am J Gastroenterol 1988;83:487-96.
57. Svartz N. Sulfasalazine, II. Some notes on the discovery and development of salazopyrin. Am J Gastroenterol 1988; 83:497-503.
58. Bargen JA. Treatment of ulcerative colitis with salicylazo-sulfapyridine (salazopyrin). Med Clin North Am 1949;33: 935-42.
59. Klotz U, Maier K, Fischer C, Heinkel L. Therapeutic efficacy of sulphasalazine and its metabolites in patients with ulcerative colitis and Crohn's disease. N Engl J Med 1980; 303:1499-502.
60. Peppercorn MA. Distribution studies of salicylazosulfapyridine and its metabolites. Gastroenterology 1973;64:240-5.
61. Azad-Khan AK, Piris J, Truelove SC. An experiment to determine the active therapeutic moiety of sulphasalazine. Lancet 1977;2:892-5.
62. Sheldon P, Webb C, Gridnulis KA. Effect of sulphasalazine and its metabolites on mitogen induced transformation of lymphocytes - clues to its clinical action. Br J Rheumatol 1988;27:344-9.
63. Gaginella TS, Walsh RE. Sulfasalazine - multiplicity of action. Dig Dis Sci 1992;37:801-12.
64. Fleming A. The 1928 discovery of penicillin. Br Med Bull 1944;2:4-5.
65. Fleming A. On the antibacterial action of a penicillium with special reference to their use in the isolation of B. influenzae. Br J Exp Pathol 1929;10:226-38.
66. Kirsner JB, Rodaniche EC, Palmer WL. The use of sulfaguanidine in non-specific ulcerative colitis and other infections of the bowel. Am J Dig Dis 1942;9:229-33.
67. Rodaniche EC, Kirsner JB, Palmer WL. Effects of oral administration of sulfonamide compounds on the fecal flora of patients with non-specific ulcerative colitis. Gastroenterology 1943;1:133-39.
68. Rodaniche EC, Palmer WL, Kirsner JB. The streptococci present in the feces of patients with nonspecific ulcerative colitis and the effect of oral administration of sulfanamide compounds upon them. J Infect Dis 1943;72:222-7.
69. Hench PS, Kendall EC, Slocumb CH, Polley HF. The effect of a hormone of the adrenal cortex (17-hydroxy-11 dehydrocorticosterone) (compound E) and of pituitary adenocorticotropic hormone on rheumatoid arthritis - preliminary report. Proc Staff Meet Mayo Clin 1949;24: 181-97.
70. Kirsner JB, Palmer WL. Effect of corticotropin (ACTH) in chronic ulcerative colitis. JAMA 1951;147:541-9.
71. Truelove SC, Witts IJ. Cortisone in ulcerative colitis. Report on therapeutic trial. Br Med J 1955;2:1041-8.
72. Schwartz RS. Immunosuppressive drugs. Prog Allergy 1965;9:246-303.
73. Salmonsen CJ, Madsen T. Sur la Reproduction de la Substance Antitoxique Apres de Fortes Saignees. Ann Inst Pasteur 1898;12:763-73.
74. Hektoen L. Effect of toluene on production of antibodies. J Infect Dis 1911;19:737-45.
75. Hektoen L, Corper HJ. Effect of mustard gas on antibody formation. J Infect Dis 1921;28:279-85.
76. Hitchings GH, Elion GB, Falco EA, et al. Studies on analogs of purines and pyrimidines. Ann NY Acad Sci 1950; 52:1318-35.
77. Hitchings GH, Elion GB, Falco EA, et al. Antagonists of nucleic acid derivatives: Lactobacillus casei model. J Biol Chem 1950;183:1-9.
78. Elion GB, Bieber S, Hitchings GH. The fate of 6 mercaptopurine in mice. Ann NY Acad Sci 1954;60:297-302.
79. Hamilton L, Elion GB. The rate of 6 mercaptopurine in man. Ann NY Acad Sci 1954;60:304-14.
80. Schwartz RS, Stack J, Dameshek W. Effect of 6-mercaptopurine on antibody production. Proc Soc Exp Biol Med 1958;99:164-7.
81. Page AH, Condie RM, Good RA. Effect of 6-mercaptopurine on inflammation. Am J Pathol 1962;40:519-30.
82. Bean RHD. The treatment of chronic ulcerative colitis with 6-mercaptopurine. Med J Aust 1962;1:592-3.
83. Bowen GE, Irons GV, Rhodes JB, Kirsner JB. Early experiences with azathioprine in ulcerative colitis. JAMA 1966;195:460-4.
84. Rosenberg JL, Levin B, Wall AJ, Kirsner JB. A controlled trial of azathioprine in Crohn's disease. Dig Dis 1975;20: 721-6.
85. Rosenberg JL, Wall AJ, Levin B, et al. A controlled trial of azathioprine in the management of chronic ulcerative colitis. Gastroenterology 1975;69:96-99.
86. Present DH, Korelitz BI, Wisch N, et al. Treatment of Crohn's disease with 6-mercaptopurine - a long term randomized double blind study. N Engl J Med 1980;302:981-7.
87. Petcher TJ, Weber HP, Ruegger A. Crystal and molecular structure of an iodo-derivative of the cyclic endica peptide cyclosporin A. Helv Clin Acta 1976;59:1480-9.
88. Ruegger A, Kuhn M, Lichti H, et al. Cyclosporin A ein Immunosuppressio Wirksauer Peptidmetabolit aus Trichoderma Polysporium (Link ex Pers.) Rifai. Helv Clin Acta 1976;59:1075-92.
89. Weir RF. A new use for the useless appendix in surgical treatment of obstinate colitis. Med Rec 1902;62:201-2.
90. Allison CC. Cecostomy: the operation of choice for temporary drainage of the colon. JAMA 1909;53:1562.
91. Brown JY. The value of complete physiological rest of large bowel in treatment of certain ulcerative and obstructive lesions of this organ. Surg Gynecol Obstet 1913;16:610-3.
92. Pennel JW. Stricture of rectum - artificial anus established in left lumbar region. Med Chir 1850;33:255-60.
93. Franke K. Colectomy or resection of the large intestine for malignant disease. Med Chir 1889;72:211-32.
94. In: Bacon HE. Ulcerative colitis. Philadelphia: Lippincott, 1958.
95. Bacon HE. Ulcerative colitis. Philadelphia: Lippincott, 1958.
96. Strombeck JF. Surgical treatment of ulcerative colitis. Acta Chir Scand 1949;98:414-27.
97. Strauss AA. Ulcerative colitis. Surg Clin North Am. 1923; 3:1033-1042.
98. Strauss AA, Friedman J, Block L. Colectomy for ulcerative colitis Surg Clin North Am 1924;4:667-86.
99. Whittaker LD. Observation on the human being following colectomy or colonie exclusion with ileostomy. Proc Staff Meeting Mayo Clin 1937;12:183-7.
100. Brooke BN, Cooke WT. Ulcerative colitis: diagnostic problems and therapeutic warning. Lancet 1951;2:462-4.
101. Brooke BN. The management of an ileostomy including its complications. Lancet 1952;2:102-4.
102. Turnbull RB. Management of an ileostomy. Am J Surg 1953;86:617-24.
103. Patey DH. Primary epithelial apposition in colostomy. Proc Roy Soc Med 1951;44:423-4.
104. Coffey RC. Two stage operation in abdominal surgery - making and closing an ileostomy opening. Trans West Surg Assoc 1916;26:159-72.
105. Aylett S. Diffuse ulcerative colitis and its treatment by ileorectal anastomosis. Ann Roy Coll Surg Engl 1960;27: 260-5.
106. Kock NG. Continent ileostomy. Progress Surg 1973;12: 180-201.
107. Dozois RR, Kelly K. Newer operations for ulcerative colitis and Crohn's disease. In: Inflammatory bowel disease. Kirsner JB, Shorter RG, eds., Philadelphia: Lea & Febiger, 1988:655-83.
108. Kelly KA. Anal sphincter-saving operations for chronic ulcerative colitis. Am J Surg 1992;163:5-11.
109. Glotzer DJ, Glock ME, Goldman H. Proctitis and colitis following diversion of the fecal stream. Gastroenterology 1981;80:438-41.
110. Korelitz BI, Cheskin IJ, Sohn N, Sommers SC. Proctitis after fecal diversion in Crohn's disease and its elimination with re-anastomosis - implications for surgical management. Gastroenterology 1984;87:710-13.
111. Harig JM, Soergel KH, Komorowski RA, Wood CM. Treatment of diversion colitis with short chain fatty acid irrigation. N Engl J Med 1989;320:23-8.
112. Roediger WE. Role of anaerobic bacteria in the metabolic welfare of the colonie mucosa in man. Gut 1989;21:793-8.
113. Block GE. Surgical management of Crohn's colitis. N Engl J Med 1980;302:1068-70.
114. Kirsner JB. Limitations in the evaluation of therapy for inflammatory bowel disease - suggestions for future research. J Clin Gastroenterol 1990;12:516-24.